AR046400A1 - Sales de pantoprazol - Google Patents
Sales de pantoprazolInfo
- Publication number
- AR046400A1 AR046400A1 ARP040102594A ARP040102594A AR046400A1 AR 046400 A1 AR046400 A1 AR 046400A1 AR P040102594 A ARP040102594 A AR P040102594A AR P040102594 A ARP040102594 A AR P040102594A AR 046400 A1 AR046400 A1 AR 046400A1
- Authority
- AR
- Argentina
- Prior art keywords
- salts
- pantoprazol
- ion
- ylmethylsulfinyl
- counterbalanced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Reivindicación 1: Sales metálicas farmacológicamente compatibles de piridin-2-ilmetilsulfinil-1H-benzimidazoles con actividad inhibitoria de H+/K+-ATPasa, caracterizadas porque al menos un equivalente de carga positiva del ión metálico está contrabalanceado por un ión hidroxilo, e hidratos de las mismas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03016760 | 2003-07-23 | ||
EP03016759 | 2003-07-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR046400A1 true AR046400A1 (es) | 2005-12-07 |
Family
ID=34117526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040102594A AR046400A1 (es) | 2003-07-23 | 2004-07-22 | Sales de pantoprazol |
Country Status (18)
Country | Link |
---|---|
US (1) | US20060189590A1 (es) |
EP (1) | EP1651217B1 (es) |
JP (1) | JP2006528158A (es) |
AR (1) | AR046400A1 (es) |
AT (1) | ATE386522T1 (es) |
AU (1) | AU2004260832A1 (es) |
CA (1) | CA2532774A1 (es) |
DE (1) | DE602004011946T2 (es) |
DK (1) | DK1651217T3 (es) |
ES (1) | ES2302007T3 (es) |
HR (1) | HRP20080191T3 (es) |
IL (1) | IL172600A0 (es) |
MX (1) | MXPA06000652A (es) |
PL (1) | PL1651217T3 (es) |
PT (1) | PT1651217E (es) |
SI (1) | SI1651217T1 (es) |
TW (1) | TW200509921A (es) |
WO (1) | WO2005011692A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2510849A1 (en) | 2002-12-19 | 2004-07-08 | Teva Pharmaceutical Industries Ltd | Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates |
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
WO2007041790A1 (en) * | 2005-10-14 | 2007-04-19 | Jon Pty Limited | Salts of proton pump inhibitors and process for preparing same |
US7576219B2 (en) | 2005-10-26 | 2009-08-18 | Hanmi Pharm. Co., Ltd | Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same |
JP5017274B2 (ja) * | 2005-10-26 | 2012-09-05 | ハンミ・サイエンス・カンパニー・リミテッド | S−オメプラゾールストロンチウム塩またはその水和物、その製造方法、及びこれを含む医薬組成物 |
PL1976532T3 (pl) | 2006-01-27 | 2016-05-31 | Univ Yale | Szybko działający inhibitor wydzielania kwasu żołądkowego |
US8512761B2 (en) | 2006-01-27 | 2013-08-20 | Yale University | Fast acting inhibitor of gastric acid secretion |
US8264615B2 (en) | 2008-06-19 | 2012-09-11 | Marvell World Trade Ltd. | Split edge enhancement architecture |
CN102336788B (zh) * | 2011-06-29 | 2014-08-27 | 涂家生 | 质子泵抑制剂氨基葡萄糖复盐 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
JPH08509738A (ja) * | 1993-04-27 | 1996-10-15 | セプラコー,インコーポレイテッド | 光学的に純粋な(+)パントプラゾールを用いる胃の疾患治療の方法と組成 |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
DE19843413C1 (de) * | 1998-08-18 | 2000-03-30 | Byk Gulden Lomberg Chem Fab | Neue Salzform von Pantoprazol |
DE10061137B4 (de) * | 2000-12-07 | 2016-10-06 | Takeda Gmbh | Neue pharmazeutische Zubereitung |
-
2004
- 2004-07-22 DK DK04742008T patent/DK1651217T3/da active
- 2004-07-22 ES ES04742008T patent/ES2302007T3/es not_active Expired - Lifetime
- 2004-07-22 EP EP04742008A patent/EP1651217B1/en not_active Expired - Lifetime
- 2004-07-22 AU AU2004260832A patent/AU2004260832A1/en not_active Abandoned
- 2004-07-22 WO PCT/EP2004/051578 patent/WO2005011692A1/en active IP Right Grant
- 2004-07-22 US US10/564,768 patent/US20060189590A1/en not_active Abandoned
- 2004-07-22 PL PL04742008T patent/PL1651217T3/pl unknown
- 2004-07-22 JP JP2006520838A patent/JP2006528158A/ja not_active Withdrawn
- 2004-07-22 CA CA002532774A patent/CA2532774A1/en not_active Abandoned
- 2004-07-22 SI SI200430707T patent/SI1651217T1/sl unknown
- 2004-07-22 AT AT04742008T patent/ATE386522T1/de not_active IP Right Cessation
- 2004-07-22 PT PT04742008T patent/PT1651217E/pt unknown
- 2004-07-22 AR ARP040102594A patent/AR046400A1/es not_active Application Discontinuation
- 2004-07-22 MX MXPA06000652A patent/MXPA06000652A/es active IP Right Grant
- 2004-07-22 DE DE602004011946T patent/DE602004011946T2/de not_active Expired - Fee Related
- 2004-07-23 TW TW093122166A patent/TW200509921A/zh unknown
-
2005
- 2005-12-15 IL IL172600A patent/IL172600A0/en unknown
-
2008
- 2008-04-28 HR HR20080191T patent/HRP20080191T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PT1651217E (pt) | 2008-05-23 |
DE602004011946D1 (de) | 2008-04-03 |
AU2004260832A1 (en) | 2005-02-10 |
EP1651217B1 (en) | 2008-02-20 |
ES2302007T3 (es) | 2008-07-01 |
DE602004011946T2 (de) | 2009-03-19 |
DK1651217T3 (da) | 2008-06-16 |
EP1651217A1 (en) | 2006-05-03 |
CA2532774A1 (en) | 2005-02-10 |
PL1651217T3 (pl) | 2008-07-31 |
HRP20080191T3 (en) | 2008-05-31 |
IL172600A0 (en) | 2006-04-10 |
ATE386522T1 (de) | 2008-03-15 |
TW200509921A (en) | 2005-03-16 |
US20060189590A1 (en) | 2006-08-24 |
SI1651217T1 (sl) | 2008-08-31 |
JP2006528158A (ja) | 2006-12-14 |
WO2005011692A1 (en) | 2005-02-10 |
MXPA06000652A (es) | 2006-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA85559C2 (en) | Aminobenzophenone compounds | |
TW200612910A (en) | Medicaments comprising carbonyl compounds, and the use thereof | |
DE602004019855D1 (de) | Sicherheitsüberwacher für einen am Telefon angebrachten Hilfsrechner | |
MX337081B (es) | Anticuerpo anti-nr10 y su uso. | |
DE602004024037D1 (de) | Substituierte heterozyklen | |
HRP20080564T3 (en) | Dihydrotetrabenazines and pharmaceutical compositions containing them | |
NO20082594L (no) | Pyrimidinylbenzotiofenforbindelser | |
NO20084024L (no) | Imidazolbaserte forbindelser, preparater omfattende slike, og anvendelse av slike | |
CR9068A (es) | Uso de un inhibidor del mtor en el tratamiento de leiomioma del utero | |
ATE400319T1 (de) | Tetrahydropyridothiophene | |
AR046400A1 (es) | Sales de pantoprazol | |
BRPI0418384A (pt) | composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes | |
ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
EA200100963A1 (ru) | Средство для лечения артрита | |
UY28344A1 (es) | Nuevos compuestos | |
EP1474396A4 (en) | N-SUBSTITUTE3-HYDROXY-4-PYRIDINONES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | |
CA109514S (en) | Door facing | |
NO20053562L (no) | Nye aminobenzofenonforbindelser | |
HRP20080179T3 (en) | Novel imidazopyridine compound ii with therapeutic effect | |
RU2005128402A (ru) | Способ определения биологического возраста человека | |
ATE495148T1 (de) | Die produktion von tnf-alpha inhibierenden 2- cyclopenten-1-onoximderivate | |
MXPA05009243A (es) | N-aril-2-oxazolidinona-5-carboxamidas y sus derivados. | |
DE602004017231D1 (de) | Immunmodulierende oxopyrazolocinnoline als cd80-inhibitoren | |
ATE348803T1 (de) | Tryptase-inhibitoren | |
PT1358182E (pt) | Derivados de diazocinas e sua utilizacao como inibidores de triptase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |